Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II.
作者信息
Kung Che-Pei, Barnoud Thibaut, Yao Cong-Hui, Bertolini Irene, Murphy Maureen E
机构信息
Department of Medicine, Division of Molecular Oncology, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, United States.
Department of Biochemistry and Molecular Biology, College of Medicine, Medical University of South Carolina, Charleston, SC, United States.
出版信息
Front Endocrinol (Lausanne). 2024 Jun 19;15:1441828. doi: 10.3389/fendo.2024.1441828. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II.
Front Endocrinol (Lausanne). 2024 Jun 19;15:1441828. doi: 10.3389/fendo.2024.1441828. eCollection 2024.
2
Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development - from basic research to translational applications.
Front Endocrinol (Lausanne). 2023 Mar 2;14:1168700. doi: 10.3389/fendo.2023.1168700. eCollection 2023.
3
Obesity and Obesity-Related Disorders-Editorial.
Int J Mol Sci. 2024 Jul 21;25(14):7954. doi: 10.3390/ijms25147954.
4
Translational potential of mouse models of human metabolic disease.
Cell. 2024 Aug 8;187(16):4129-4143. doi: 10.1016/j.cell.2024.07.011. Epub 2024 Jul 26.
5
Preface to special issue on: Adiposopathy in Cancer and (Cardio)Metabolic Diseases: an Endocrine Approach - Part 4.
Horm Mol Biol Clin Investig. 2015 Jul;23(1):1-4. doi: 10.1515/hmbci-2015-0037.
6
Gut microbiota in human metabolic health and disease.
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.
7
Editorial: Translational research in thyroid cancer, Volume II.
Front Endocrinol (Lausanne). 2023 Jun 13;14:1223976. doi: 10.3389/fendo.2023.1223976. eCollection 2023.
8
Editorial: Double-Edged Swords: Genetic Factors That Influence the Pathogenesis of Both Metabolic Disease and Cancer.
Front Endocrinol (Lausanne). 2019 Jul 3;10:425. doi: 10.3389/fendo.2019.00425. eCollection 2019.
9
Recent advances in PTP1B signaling in metabolism and cancer.
Biosci Rep. 2021 Nov 26;41(11). doi: 10.1042/BSR20211994.
10
Spotlight on zebrafish: the next wave of translational research.
Dis Model Mech. 2019 Mar 7;12(3):dmm039370. doi: 10.1242/dmm.039370.
本文引用的文献
1
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
Br J Cancer. 2024 Mar;130(5):703-715. doi: 10.1038/s41416-023-02502-9. Epub 2023 Nov 27.
2
Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism.
Discov Oncol. 2023 Feb 22;14(1):23. doi: 10.1007/s12672-022-00599-7.
3
Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma.
Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
4
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products.
Molecules. 2021 Apr 10;26(8):2179. doi: 10.3390/molecules26082179.
5
Oncometabolites in Cancer: Current Understanding and Challenges.
Cancer Res. 2021 Jun 1;81(11):2820-2823. doi: 10.1158/0008-5472.CAN-20-3730. Epub 2021 Mar 24.
6
A view on drug resistance in cancer.
Nature. 2019 Nov;575(7782):299-309. doi: 10.1038/s41586-019-1730-1. Epub 2019 Nov 13.
Zotero 插件